Hydrochloric Acid

Hydrochloric Acid

SCHEMBL9938710

CC(C)(C)P(c1ccc(C(F)(F)F)cc1)C(C)(C)C.CC(C)(C)P(c1ccc(C(F)(F)F)cc1)C(C)(C)C.[Cl-].[Cl-].[Pd+2]

nearest known ligand 0.40

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

ACHEBDKRB2CHRM1CHRM2CHRM3CHRNA1CHRNB1CHRNDCHRNECHRNGGUCY1A1GUCY1A2GUCY1B1GUCY1B2NAMPTPTAFRSLC10A2SLC6A2SLC6A3TACR1dacAdacBdacCftsImrcAmrcBmrdA

The experimentally established mechanism targets of Hydrochloric Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 14)

geneUniProtsupporting neighboursconfidence
KIF11 P52732 7/20 0.40
ALDH1A1 P00352 1/20 0.37
TSHR P16473 1/20 0.37
CES2 O00748 1/20 0.35
CES1 P23141 1/20 0.35
ORAI1 Q96D31 1/20 0.35
ORAI2 Q96SN7 1/20 0.35
ORAI3 Q9BRQ5 1/20 0.35
TRPV6 Q9H1D0 1/20 0.35
MGLL Q99685 1/20 0.35
AHR P35869 1/20 0.33
TAAR1 Q96RJ0 1/20 0.33
TRPV1 Q8NER1 1/20 0.33
PDE2A O00408 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2551861 0.96 ALDH1A1 (0.40) KIF11ALDH1A1TSHRCES2CES1
SCHEMBL14811633 0.93 ALDH1A1 (0.39) KIF11ALDH1A1TSHRCES2CES1
SCHEMBL23145206 0.88 AHR (0.35) KIF11ALDH1A1TSHRCES2CES1
SCHEMBL2557952 0.78
SCHEMBL2548631 0.77 TSHR (0.48) KIF11ALDH1A1TSHR
SCHEMBL3817848 0.75 ALDH1A1 (0.39) KIF11ALDH1A1TSHRCES2CES1
Hydrochloric Acid SCHEMBL29591258 0.75 TSHR (0.46) KIF11ALDH1A1TSHR
SCHEMBL29670197 0.75 TSHR (0.46) KIF11ALDH1A1TSHR
SCHEMBL2550800 0.73 CES2 (0.38) KIF11CES2PDE2A
Hydrochloric Acid SCHEMBL18796541 0.72

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11760741-B2 Pro-drugs of eliglustat KASHIV BIOSCIENCES, LLC (US) 2023-09-19 US disclosed
US-20220389310-A1 LUMINESCENT MATERIALS AND METHODS THEREOF UNIVERSITY OF WASHINGTON (US) 2022-12-08 US disclosed
WO-2021062035-A1 LUMINESCENT MATERIALS AND METHODS THEREOF UNIVERSITY OF WASHINGTON (US) 2021-04-01 WO disclosed
WO-2012079583-A1 SYSTEM PROVIDING CONTROLLED DELIVERY OF GASEOUS CO FOR CARBONYLATION REACTIONS AARHUS UNIVERSITET (DK) 2012-06-21 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11760741-B2 Pro-drugs of eliglustat GCG, GLP1R, PROKR1 KIF11 2009/4885ALDH1A1 925/4885TSHR 3101/4885
US-20220389310-A1 LUMINESCENT MATERIALS AND METHODS THEREOF TYR, GSTA2, CYBA KIF11 3462/4885ALDH1A1 479/4885TSHR 4145/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.